SCHEMBL27447192

SCHEMBL27447192

CC(C)[C@H](NC(=O)CCOCCOCCOCCOCCN)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ FURIN P09958 9/20 0.39
▸ CHRNA1 P02708 2/20 0.38
▸ CHRNG P07510 2/20 0.38
▸ CHRNB1 P11230 2/20 0.38
▸ CHRND Q07001 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ KLKB1 P03952 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPY1R P25929 3/20 0.36
▸ NPY4R P50391 2/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ NPY2R P49146 1/20 0.35
▸ NPY5R Q15761 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22138596 1.00 FURIN (0.39) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL20705515 1.00 FURIN (0.39) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL15699736 0.94 FURIN (0.40) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL25787504 0.94 FURIN (0.40) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL30297062 0.93 HTT (0.41) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL22138594 0.93 FURIN (0.39) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL19681567 0.93 FURIN (0.39) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL24296990 0.93 FURIN (0.40) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL23429029 0.92 HTT (0.41) FURINCHRNA1CHRNGCHRNB1CHRND
SCHEMBL24864407 0.92 FURIN (0.39) FURINHTTNPY1RNPY4RROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024138000-A1 PRODRUGS OF TOPOISOMERASE I INHIBITOR FOR ADC CONJUGATIONS AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2024-06-27 — — WO disclosed
Send feedback